Mind Cure Health Inc. Announces Participation in the Benzinga Global Small Cap Conference

Mind Cure Health Inc. (CSE: MCUR) will be presenting at the Benzinga Global Small Cap Conference taking place on December 8-9, 2020. We invite our shareholders and all interested parties to explore small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/

About the Benzinga Global Small Cap Conference

The Benzinga Global Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined educational modules, take a look at a curated group of small cap investment opportunities, and connect with the global small cap audience in an intimate, virtual setting.

For more information and/or to register for the conference please visit: https://events.benzinga.com/registration-page

We look forward to seeing you there.

For further information:

Mind Cure Health Inc.
Kelsey Ramsdaen
1-519-318-3505
kramsden@mindcure.com
www.mindcure.com

News Provided by Newsfile via QuoteMedia

The Conversation (0)
Mind Cure

Mind Cure

Overview

Mind Cure (CSE:MCUR,OTCQB:MCURF) is a mental health and wellness company that is dedicated to investigating the potential of psychoactive, psychedelic, and nootropic compounds to treat what the World Health Organization (WHO) has labeled a global mental health crisis. The company has developed a unique “Five Spheres” framework to structure its approach to mental health investigation. The five spheres cover Mind Cure’s interest in psychedelic research, digital therapeutics, psychedelic drug discovery, formulation and nootropics.

According to the WHO, roughly 450 million people worldwide are suffering from mental or neurological disorders. In Canada, the total cost from mental health problems and disorders has been conservatively estimated to be at least C$50 billion per year, representing 2.8 percent of the country’s GDP. The economic burden of mental health problems has led the United Nations to urge governments to seek, develop and implement affordable solutions.

Keep reading...Show less

Investigating and Developing Psychoactive Therapies and Products

Latest Press Releases

Related News